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Abstract
Perioperative anaesthetic management of patients
with pulmonary hypertensive crisis is complex and
challenging because of limited window period and
treatment options. This case report describes the
successful management of a patient with severe
valvular heart disease superimposed by severe
pulmonary hypertension, who developed pulmonary
hypertensive crisis soon after induction of general
anaesthesia for cardiac surgery.  Pulmonary
hypertensive crisis is not a usual phenomenon in these
patients, but if it occurs it can be fatal. Anticipatory
care of the patient to prevent crisis is the mainstay of
treatment, otherwise it adds additional morbidity to
such patients. Fortunately our patient survived the
crisis without causing any additional morbidity during
his hospital stay.
Keywords: Pulmonary hypertensive crisis, General
anaesthesia, Perioperative management, Severe
pulmonary hypertension.
Introduction
The haemodynamic definition of Pulmonary
hypertension is when resting mean pulmonary artery
pressure is  > 25mmHg, Pulmonary Capillary wedge
Pressure/Left Atrial Pressure <15 mmHg and
Pulmonary vascular resistance of > 3 wood units, as
measured by right heart catheterization.1 Pulmonary
hypertension is severe and supra systemic when mean
pulmonary artery pressure is > 50mmHg and >
60mmHg respectively. Patients with severe pulmonary
hypertension have higher mortality about 4%-24%
during surgical procedures.2
Rationale for writing this case report is dissipating
knowledge and awareness about a rare and fatal event
in patients with severe pulmonary artery hypertension.
Case History
A 45 years old male, snuff user, banker by profession,
known case of valvular heart disease, presented in the
cardiothoracic clinic of Aga Khan University Hospital,
on 18 February 2013 with worsening exertion
dyspnoea, orthopnoea, syncope and palpitation since
1 year. He was referred from another city for valve
replacement surgery at our hospital. On preoperative
assessment, he was a young, alert and normal built
man. His functional class was III (Marked limitation in
less than ordinary activity) according to New York
Heart Association (NYHA) classification.3 On
Auscultation, there was mid diastolic murmur and
decreased air entry over the right lower zone. Airway
assessment revealed Mallampati of class I. Twelve lead
Electrocardiography showed sinus rhythm, right
ventricular hypertrophy and T- wave inversion in
anterior leads. Echocardiography revealed Ejection
fraction of 55%, severely dilated left atrium, severe
pulmonary hypertension, severe stenosis of Mitral
valve with area of 0.7cm2, and moderate stenosis of
Aortic valve with area of 1.2cm2. Chest x-ray showed
right sided pleural effusion and other investigations
were within normal limits.
Patient was pre-medicated with oral midazolam 7.5mg
with oxygen supplementation. After application of
standard anaesthesia monitoring, left radial artery was
cannulated under local anaesthesia for invasive blood
pressure monitoring. Anaesthesia was induced with
intravenous injection of 2mg midazolam, 2ug/kg
fentanyl, 0.2mg/kg etomidate and 0.9mg/kg
rocuronium. Endotracheal intubation was performed
and controlled mode ventilation initiated. Anaesthesia
was maintained with 50%oxygen with air and
isoflurane. A triple lumen 15cm Central venous
catheter was inserted in right internal jugular vein with
ultrasound guidance and pulmonary artery catheter
was floated through the swanz sheath at the same
place. Immediate pulmonary pressures were high as
expected, with systolic, diastolic and mean pressures of
92/49mmHg and 63mmHg respectively, low normal
Systemic vascular resistance of 799 dynes/cm5 and
high cardiac output of 7.3L/min. Patient was positioned
supine with both legs slightly elevated for surgical
procedure and preparation for surgery was started. It
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was immediately noticed that the Pulmonary pressures
was elevated to 155/55mmHg, much higher than the
systemic pressures. This was managed as pulmonary
hypertension crisis. 
The possible triggering factor was not figured out
exactly but it was thought that, light phase of
anaesthesia during positioning for the procedure
probably led to the crisis. Immediately 100% oxygen
was administered, epinephrine infusion 0.2ug/kg/min
and dobutamine infusion 5ug/kg/min were started
simultaneously for cardiac support. Glycerine
trinitrate infusion 1ug/kg/min-2ug/kg/min was
started to achieve pulmonary vasodilation by
increasing cyclic Guanosine Monophosphate in the
constricted pulmonary vasculature.4,5 Nebulized
through endotracheal tube continuously with
Alprostadil (prostaglandin E1) at a rate of 5ml/hour, a
potent inhaled pulmonary vasodilator. Pulmonary
pressures settled down gradually to 90/50mmHg and
surgery was started after successful management of
the crisis.
Surgery went uneventful with pump time of 180
minutes and cross clamp time of 150 minutes.
Diseased mitral and aortic valves were replaced with
tissue valves. The patient was weaned off from the
pump with high inotropic support and shifted to
Cardiac Intensive Care Unit. He was extubated on 2nd
postoperative day when inotropic support was
minimal and was started on sildenafil
(phosphodiestarse inhibitor) 25mg given through
nasogastric tube.  Pulmonary pressures were
continuously monitored, with trends remaining low
48/32, 50/25, 46/18mmHg throughout his stay in CICU.
Patient was discharged after complete recovery and
cardiac rehabilitation. He remained well on the follow
up visit in the clinic and was advised to travel back to
his city in a month. He continued his job in the bank
and is now living his life with improved quality. 
Patient was contacted through phone for his
wellbeing after a year and was requested for written
informed consent for publishing his case report in a
journal for the reason of dissipating the knowledge
among health care providers for which he agreed
upon and documents were exchanged through
courier.
Discussion
Pulmonary hypertension crisis is a life threatening
condition in which series of events culminate in
biventricular failure and death. It is characterized by
an acute rise in pulmonary pressures to the point
where it exceeds systemic pressures due to rapid
increase in pulmonary vascular resistance, causing
pressure overload of right ventricle, decrease
pulmonary blood flow, hypoxia, and decrease cardiac
output due to leftward displacement of the inter
ventricular septum with impending cardiac failure.
Perioperative Pulmonary hypertension is associated
with worse outcome and mortality rate may exceed
50%.6 Anaesthesia related risk factors for perioperative
pulmonary hypertensive crisis are hypercarbia,
hypoxia, painful stimuli, acidosis and airway
instrumentation, which leads to rapid increase in
pulmonary vascular resistance.7 The best way to
prevent such a predictable event is to be prepared for
it ahead of time. Anaesthetic management goals are to
provide adequate anaesthesia and analgesia, vigilant
invasive haemodynamic monitoring, avoidance of
stimuli causing pulmonary vasoconstriction and
maintenance of cardiovascular stability. Confirmation
of pulmonary hypertensive crisis if occurred, is via
invasive haemodynamic monitoring through
pulmonary artery catheter, parameters such as rising
right atrial and pulmonary pressures with decreasing
cardiac output are the hallmark.
Perioperative pulmonary hypertensive crisis mandates
immediate management to decrease pulmonary
vascular resistance by pulmonary vasodilators either
intravenous or inhalational, inotropic support and
identification of the cause. Supportive measures with
100% oxygen, hyperventilation to decrease CO2, and
treating acid base disturbance are also proven to
prompt pulmonary vasodilation.
Conclusion
Patient with severe pulmonary artery hypertension are
at high risk for pulmonary hypertensive crisis during
surgical procedures, therefore immediate recognition
and prompt treatment is the mainstay of successful
management.
Disclaimer: This case was seen on 18th Feb 2013 and
was presented as interesting case in the weekly
departmental meeting of department of
Anaesthesiology at Aga Khan University Hospital
Karachi on 18th March 2013.
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